Showing posts with label medical devices. Show all posts
Showing posts with label medical devices. Show all posts

Friday, April 19, 2024

Elevating Healthcare Infrastructure: “Hospital Beds Market” Projected to Reach $6.66 Billion by 2030

 

Meticulous Research®, a premier global market research company, has unveiled its latest research report titled 'Hospital Beds Market by Product (Bed, Accessories), Technology (Manual, Powered), Type of Care (Rehabilitative, Curative, Long Term), Healthcare Facility (Pediatric, Maternal, Bariatric, Critical, Homecare, Med Surg) - Global Forecast to 2030.'

Download Free Research PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5091

 According to this comprehensive study, the global hospital beds market is poised to attain a valuation of $6.66 billion by the year 2030, exhibiting a robust CAGR of 6.4% during the forecast period spanning from 2023 to 2030. The market's growth trajectory is chiefly propelled by several factors, including the burgeoning elderly population, escalating prevalence of chronic diseases, proliferation of hospitals worldwide, and the introduction of cutting-edge technological innovations in bed designs. Moreover, the advent of smart and robotic beds, coupled with the escalating demand for beds in homecare settings and the burgeoning medical tourism sector in emerging economies, presents lucrative opportunities for hospital bed vendors on a global scale.

Future Outlook of the Hospital Beds Market

The global medical beds market is meticulously segmented based on Product (Beds, Accessories), Technology (Powered Beds [Electric Beds, Semi-electric Beds], Manual Beds, Smart Beds), Type of Care (Curative Care, Long-term Care, Rehabilitative Care), Healthcare Facility (Critical Care Unit, Long-term Care Unit, Bariatric Care Unit, Med-Surg Care Unit, Pediatric Care Unit, Maternal Care Unit, Home Care Settings), and Geography. This detailed segmentation enables a profound analysis of industry competitors and their market shares at both global and regional levels.

Have Any Query? Speak To Our Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5091

In terms of product segmentation, the beds segment is anticipated to hold the largest market share in 2023, primarily driven by the high prevalence of acute and chronic diseases, including recent outbreaks such as COVID-19 and Ebola, alongside the proliferation of hospitals. Moreover, advancements in medical bed technologies are further fueling the adoption of medical beds.

The technology segment is divided into powered beds, manual beds, and smart beds, with the powered beds segment projected to dominate the market in 2023. This dominance can be attributed to the myriad advantages offered by powered beds, including enhanced comfort, improved sleep quality, and increased independence among the elderly populace.

Browse in depth @ https://www.meticulousresearch.com/product/hospital-beds-market-5091

Additionally, the type of care segmentation reveals that the curative care segment is poised to command the largest market share in 2023, driven by the increasing adoption of medical beds for curative treatments of acute and chronic illnesses. However, the long-term care segment is expected to register the highest CAGR during the forecast period, owing to the rapidly rising global geriatric population requiring prolonged care for chronic illnesses.

Furthermore, the home care settings segment is anticipated to witness the fastest growth rate over the forecast period, attributed to the increasing aging population opting for long-term care at home, offering an affordable and convenient alternative for elderly care.

Geographic Review

The report provides a comprehensive geographic analysis covering major regions, including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Notably, Asia-Pacific is forecasted to register the highest CAGR during the forecast period, fueled by factors such as the burgeoning geriatric population, rising prevalence of chronic diseases, increasing healthcare investments, and the expanding hospital infrastructure across the region.

Stay Ahead of the Curve with Our Insightful Analysis:  https://meticulousblog.org/top-10-companies-in-hospital-medical-beds-market/

 

___Related Research:

>> The Asia-Pacific Hospital Beds Market will grow at a CAGR of 5.8% from 2018 to reach $682.2 million by 2025 >>> https://meticulousblog.org/top-10-companies-in-asia-pacific-hospital-beds-market/?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=08-04-2024

 

>> Middle East & Africa Hospital Beds Market by Product (Bed, Accessories) Technology (Manual, Powered, Smart) Type of Care (Rehabilitative, Curative, Long-term) Healthcare Facility (Maternal, Pediatric, Critical, Homecare, Med-surg) - Forecast to 2030 >>  https://www.meticulousresearch.com/product/middle-east-and-africa-hospital-beds-market-5740?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=08-04-2024

 

>> Europe Hospital Beds Market by Product (Bed, Accessories), Technology (Manual, Powered), Type of Care (Rehabilitative, Curative, Long Term), Healthcare Facility (Pediatric, Maternal, Bariatric, Critical, Homecare, Med Surg) - Forecast to 2030 >> https://www.meticulousresearch.com/product/europe-hospital-beds-market-4626?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=08-04-2024

Wednesday, March 20, 2024

Digital X-ray Systems Market: Technology and Application

 

Meticulous Research®—a leading market research company, published a research report titled, ‘Digital X-ray Systems Market by Product (Fixed [Ceiling, Floor], Portable, Detectors, Software & Services) Technology (Computed, Direct) Application (Orthopedic & Trauma, Breast, Chest & Lung) End User (Hospital, Imaging Center) - Global Forecast to 2030.’

 

Download Free Research PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=1183?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=20-03-2024

 

According to this latest publication from Meticulous Research®, the digital X-ray systems market is projected to reach $13.29 billion by 2030, at a CAGR of 7.8% from 2023 to 2030. The growth of this market is driven by the growing burden of chronic diseases, the increasing adoption of teleradiology, and technological advancements leading to a higher preference for digital X-ray systems. However, the high costs of digital X-ray systems are restraining the market’s growth.

 

Furthermore, emerging economies and the increasing integration of Artificial Intelligence (AI) into digital X-ray systems are expected to offer significant market growth opportunities. The lack of skilled professionals poses a major challenge to the market’s growth.

 

The key players profiled in the digital X-ray systems market report are Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (U.S.), Canon Inc. (Japan), Shimadzu Corporation (Japan), FUJIFILM Holdings Corporation (Japan), Carestream Health, Inc. (U.S.), Agfa-Gevaert NV (Belgium), Hologic, Inc. (U.S.), Konica Minolta, Inc. (Japan), Samsung Medison Co., Ltd. (South Korea), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China).

 

TOP 10 COMPANIES IN DIGITAL X-RAY SYSTEMS MARKET >> https://meticulousblog.org/top-10-companies-in-digital-x-ray-systems-market/?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=20-03-2024

 

The digital X-ray systems market is segmented by Product Type [Fixed Digital X-ray Systems (Ceiling Mounted, Floor Mounted), Portable Digital X-ray Systems, Detectors, Software & Services], Technology [Direct Radiography, Computed Radiography], Application [Orthopedic & Trauma, Breast Imaging, Dental Imaging, Chest & Lung Imaging, and Other Applications], End User [Hospitals & Clinics, Diagnostic Imaging Centers], and geography. The study also evaluates industry competitors and analyzes the regional and country-level markets.

 

Based on product type, the digital X-ray systems market is segmented into fixed digital X-ray systems, portable digital X-ray systems, detectors, and software & services. In 2023, the fixed digital X-ray systems segment is expected to account for the largest share of the digital X-ray systems market.

 

The fixed digital X-ray systems segment is further divided into ceiling-mounted and floor-mounted. These systems are widely used in hospitals and diagnostic centers. With the rising number of hospitals and diagnostic imaging centers, the adoption of fixed digital X-ray systems has increased, further contributing to the segment’s large market share.

 

Browse in depth @  https://www.meticulousresearch.com/product/digital-x-ray-systems-market-1183?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=20-03-2024

 

Based on technology, the digital X-ray systems market is segmented into direct radiography (DR) and computed radiography (CR). In 2023, the direct radiography segment is expected to account for the largest share of the digital X-ray systems market. Direct radiology transfers and displays the images at a faster rate compared to computed radiology. The technology produces high-quality images and has less risk of overexposure to radiation, contributing to the largest share of this segment.

 

Based on application, the digital X-ray systems market is segmented into orthopedic & trauma, breast imaging, dental imaging, chest & lung imaging, and other applications. In 2023, the orthopedic & trauma segment is expected to account for the largest share of the digital X-ray systems market. The rise in orthopedic conditions, the advantages of digital X-ray devices over traditional devices for screening these disorders, technological advancements in modalities, and the increased number of road accidents are the major contributing factors for the segment’s largest share.

 

Speck to our analyst @   https://www.meticulousresearch.com/speak-to-analyst/cp_id=1183?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=20-03-2024

 

Based on end user, the digital X-ray systems market is segmented into hospitals and clinics, and diagnostic imaging centers. In 2023, the hospitals and clinics segment is expected to account for the largest share of the digital X-ray systems market. Hospitals & clinics perform a wide range of diagnoses and surgeries, which include the use of X-rays. The increased hospitalizations due to the rising incidence of diseases, the rise in the geriatric population, and the increase in healthcare settings support the largest share of the market.

This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and the Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa. In 2023, North America is expected to account for the largest share of the digital X-ray systems market, followed by Europe and Asia-Pacific. The well-established healthcare system, awareness regarding early disease diagnosis, and higher spending on healthcare are the major factors contributing to the large share of this market.

 

Request Free Research Report Sample @ https://www.meticulousresearch.com/request-sample-report/cp_id=1183?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=20-03-2024

Wednesday, February 21, 2024

Wearable Medical Devices Market: Type, and Opportunity

 

Meticulous Research®—a leading market research company, published a research report titled, 'Wearable Medical Devices Market by Type (Smart Watch, Activity Monitor, Patch), Application (Monitoring {Glucose, BP, Sleep, RPM}, Therapeutic {Pain, Rehabilitation, Insulin), Grade (Consumer, Medical), Distribution Channel – Global Forecast to 2030.’

 

Download Free Research PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5524?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=21-02-2024

 

According to this latest publication from Meticulous Research®, the wearable medical devices market is projected to reach $184.49 billion by 2030, at a CAGR of 19.5% from 2023 to 2030. The growth of the wearable medical devices market is driven by several factors, including growing efficiency and accuracy regarding patient data, increasing geriatric population, increasing prevalence of chronic diseases, and increasing adoption of home healthcare as an alternative to hospitals. Factors such as the potential to expand in emerging economies, an increase in the use of telehealth and services, and technological advancements in sensor technologies are a few of the opportunities that would help grow the market in the future.

 

Factors such as lack of privacy and the high cost of wearable medical devices could be considered challenges for the market. However, the manufacturing defects concerned with these wearable medical devices and the reluctance to adopt newer technologies compared to traditional healthcare technologies restrain the market's growth.

 

Browse in depth @ https://www.meticulousresearch.com/product/wearable-medical-devices-market-5524?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=21-02-2024

 

The key players profiled in the wearable medical devices market report are Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), Fitbit, Inc. (U.S.), Apple, Inc. (U.S.), OMRON Corporation (Japan), VitalConnect, Inc. (U.S.), Garmin Ltd. (U.S.), Sotera Digital Health (U.S.), Abbott Laboratories (U.S.), DexCom, Inc. (U.S.), and Withings (France).

 

The wearable medical devices market is segmented by Type (Smartwatches, Activity Monitors, Patches/Stick-Ons, Other Types), Application [Diagnostic and Monitoring Devices {Vital Monitoring Devices, Glucose Monitoring Devices, Blood Pressure Monitoring Devices, Sleep Monitoring Devices, Respiratory Monitoring Devices, Other Diagnostic and Monitoring Applications}, Therapeutic Devices {Pain Management Devices, Rehabilitation Devices, Insulin Delivery, Other Therapeutic Applications}], Distribution Channel (E-commerce, Hospitals & Pharmacies, Retail Channels), Grade (Consumer Grade, Medical Grade), and Geography. The study also evaluates industry competitors and analyzes the regional and country-level markets.

 

Speck to our analyst @   https://www.meticulousresearch.com/speak-to-analyst/cp_id=5524?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=21-02-2024

 

Based on type, in 2023, the smartwatches segment is expected to account for the largest share of the market due to their benefits, such as easy availability, reasonable costs and quick outcomes or results of health parameters such as step counts, heart rate, oxygen levels, and blood pressure. Apart from this, most wearables are only concerned with monitoring or treating a certain kind of disease or condition, whereas smartwatches measure many vitals such as blood pressure, oxygen levels, and sleeping patterns all at the same time. These features are driving the demand among consumers to buy smartwatches and follow fitness regimes for a healthy lifestyle, thus leading to the growth of this market.

 

Based on application, the diagnostic and monitoring devices segment is expected to account for the largest share of the market. These devices are used to monitor the vital signs produced by the body, such as blood pressure, oxygen levels, heart rate, and sleep data. The use of wearable medical devices has been growing gradually over the years, but it has seen a sudden jump after the pandemic. Factors such as improved patient health and data handling, increasing self-monitoring and patient engagement, and increasing prevalence of chronic diseases drive the growth of this segment.

 

Request Free Research Report Sample @ https://www.meticulousresearch.com/request-sample-report/cp_id=5524?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=21-02-2024

 

Based on distribution channel, the E-commerce segment is projected to register the highest CAGR during the forecast period. E-commerce distribution channels are becoming popular as consumers prefer to purchase devices through E-commerce websites. This is due to its ease of access, affordable rates, doorstep delivery, and convenience. Additionally, 24/7 buying, selling and customer support for the devices sold and a large variety of products drive the growth of this segment.

 

Based on grade, in 2023, the consumer grade segment is expected to account for the largest share of the market. Consumer grade includes products or devices developed by wearable device companies but not approved by a government organization such as the FDA and cannot be used for clinical purposes. Apart from this, increasing awareness of fitness and a healthy lifestyle is leading people to buy these devices. Easy health and fitness tracking, low-cost devices, variety of choices of wearables are some of the factors driving this segment's growth.

 

This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and the Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), Latin America, and the Middle East & Africa. In 2023, North America is expected to account for the largest share of the wearable medical devices market, followed by Europe and Asia-Pacific. North America’s major market share is attributed to the increasing geriatric population, high prevalence of chronic diseases, the rising popularity of wearable devices due to new and advanced features for health and fitness tracking, and large amounts of disposable income driving the market growth in North America.

 

Download Free Research PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5524?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=21-02-2024

Friday, December 1, 2023

Wearable Medical Devices: Useful in Monitoring Patients Health

 

According to a new market research report, ‘Wearable Medical Devices Market by Type (Smart Watch, Activity Monitor, Patch), Application (Monitoring {Glucose, BP, Sleep, RPM}, Therapeutic {Pain, Rehabilitation, Insulin), Grade (Consumer, Medical), Distribution Channel – Global Forecast to 2030’, published by Meticulous Research®, the wearable medical devices market is projected to reach $184.49 billion by 2030, at a CAGR of 19.5% from 2023 to 2030.

 

Wearable devices are used to monitor vital parameters, such as blood pressure, blood glucose, oxygen levels, and sleep tracking, among others. They are also used as therapeutic devices for pain management, rehabilitation, and drug delivery. These devices or technologies come under a large spectrum of usability, including smartwatches, fitness trackers, continuous glucose monitoring patches, smart glasses, smart clothing, shoe sensors, and pain-reducing capacity, among others. This range of devices is used for various applications, such as blood glucose monitoring, blood pressure monitoring, sleep monitoring, neurological monitoring, baby monitoring, pain management, orthopaedic management, and smart wound care management, among others.

 

Download Free Sample Report Now: https://www.meticulousresearch.com/download-sample-report/cp_id=5524?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=01-12-2023

 

The growth of the wearable medical devices market is driven by several factors, including growing efficiency and accuracy regarding patient data, increasing geriatric population, increasing prevalence of chronic diseases, and increasing adoption of home healthcare as an alternative to hospitals. Factors such as the potential to expand in emerging economies, increase in the use of remote patient monitoring and telehealth services, increasing patient awareness, and technological developments are a few of the opportunities that would help grow the market in the future. Lack of privacy and the high cost of wearable medical devices could be considered challenges for the wearable medical devices market. However, the manufacturing defects concerned with these wearable medical devices and the reluctance to adopt newer technologies compared to traditional healthcare technologies restrain the market's growth.

 

The report also includes an extensive assessment of the product portfolio, geographic analysis, and key growth strategies adopted by leading market players in the last three to four years. In recent years, the wearable medical devices market has witnessed several organic and inorganic strategic developments. The key players profiled in the wearable medical devices market report are Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), Fitbit, Inc. (U.S.), Apple, Inc. (U.S.), OMRON Corporation (Japan), VitalConnect, Inc. (U.S.), Garmin Ltd. (U.S.), Sotera, Inc. (U.S.), F. Hoffmann La-Roche (Switzerland), DexCom, Inc. (U.S.), and Withings (France).

 

Increasing Geriatric Population to Drive the Growth of this Wearable Medical Devices Market

 

Wearable medical devices are playing an increasingly important role in healthcare, and they have specific benefits for the geriatric population. These devices are designed to be worn on the body and collect health-related data, providing valuable insights into an individual's well-being. Some of the devices included in this market are smartwatches and patches/stick-ons. The use of these devices is increasing rapidly due to their popularity in tracking heart rate, blood pressure, and other vital signs. Due to their rising popularity, these devices are now being used by many older people and are becoming quite useful for them as it reduces their risk of infection due to traveling to a hospital or clinic for treatment or consultation and saves time and money.

 

Have Any Query? Ask To Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5524?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=01-12-2023

 

According to the United Nations, the population of age 65 or above in the world is expected to increase from 703 million people in 2019 to 1.5 billion in 2050. Also, according to the American Hospital Association, the number of people in the U.S. with a chronic medical condition is projected to rise from 149 million in 2015 to 171 million in 2030. Wearable devices allow healthcare providers to remotely monitor the health of geriatric patients, even when they are at home or in assisted living facilities. These devices can track vital signs such as heart rate, blood pressure, and oxygen levels, providing real-time data to healthcare professionals. Remote monitoring reduces the need for frequent hospital visits and enables early detection of potential health issues. Thus, the rise in the geriatric population would indirectly lead to the increase in the factors mentioned above, leading to the market's growth. Wearable devices can help older adults manage their medication schedules more effectively. They can send reminders to take medications at the right time and track adherence. Some devices can even dispense medication automatically or provide visual and auditory cues to assist with medication management.

 

The wearable medical devices market is segmented by Type (Activity Monitors, Smartwatches, Patches/Stick-Ons, and Other Types), Application [Diagnostic and Monitoring {Vital Signs Monitoring, Glucose Monitoring, Blood Pressure Monitoring, Sleep Monitoring, Respiratory Monitoring, Other Diagnostic and Monitoring Applications}, Therapeutics {Pain Management, Rehabilitation, Insulin Delivery, and Other Therapeutic Applications}], Distribution Channel (Hospitals & Pharmacies, E-commerce, and Retail Channels), Grade (Consumer and Medical Grade), and Geography. The study also evaluates industry competitors and analyzes the regional and country-level markets.

 

Based on type, in 2023, the smartwatches segment is expected to account for the largest share of the market. Factors such as a rising consumer base using smartwatches for health monitoring, an increasing number of product launches, and increased health awareness for chronic disease management and prevention drive the growth of this segment. Smartwatches equipped with optical heart rate sensors can continuously monitor the wearer's heart rate throughout the day. This feature is particularly valuable for older adults who may need to keep track of their heart health or detect irregularities in their heart rhythm. Some smartwatches can even alert users to abnormal heart rates or arrhythmias.

 

Based on application, the diagnostic and monitoring segment is expected to account for the largest share of the market. Diagnostic and monitoring devices monitor vitals and have data storage and transmission capabilities. Continuous glucose monitoring, blood pressure monitoring and heart rate monitoring are some of the vitals that can be monitored using these devices. Apart from this, the geriatric population is increasing rapidly worldwide, and in some cases, would need round-the-clock guidance for diagnosing, managing, and treating disorders like diabetes. This could be provided by diagnostic and monitoring devices paired with easier and more accurate patient health and data management, increasing patient population and self-awareness of patients leading to a large share of this segment in the market.

 

Quick Buy – Wearable Medical Devices Market- Global Opportunity Analysis and Industry Forecast (2023-2030), Research Report: https://www.meticulousresearch.com/Checkout/75466722?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=01-12-2023

 

Based on distribution channel, the E-commerce segment is projected to register the highest CAGR during the forecast period. E-commerce platforms often offer competitive pricing due to reduced overhead costs compared to traditional brick-and-mortar stores. Additionally, there are frequent sales, discounts, and promotional offers available online, allowing customers to save money when purchasing wearable medical devices. This can be advantageous for the geriatric population, especially those on fixed incomes or with limited financial resources. There has been an increased demand for wearable medical devices since the pandemic. Companies provide these wearables on their website or other commercial websites. The benefits of E-commerce as a distribution channel, such as high convenience, ease of access, attractive discounts, and increased internet penetration, are factors driving this segment's growth.

 

Based on grade, in 2023, the consumer grade segment is expected to account for the largest share of the market. Companies such as Apple, Inc. (U.S.) and Fitbit, Inc. (U.S.) are now turning to develop medical devices that are easy to handle or carry and can monitor vital signs or other health-related data remotely. This is mainly due to the increasing understanding of people for maintaining a healthy lifestyle and tracking their fitness goals to avoid health issues or disorders in the near future. Alongside this, the increasing customer pool for consumer-grade devices due to new technologies and features in the devices and new consumer product launches drive the growth of the segment.

 

Based on geography, the market in North America is expected to account for the largest share of the market. The growth of this regional market is primarily driven by increased R&D expenditure and high technological innovation in smart devices, high disposable income in this region, and the increased trend of adopting smart devices for health & fitness monitoring. Additionally, the increasing geriatric population and the high prevalence of chronic diseases contribute to the growth of this market. However, Asia-Pacific is expected to witness rapid growth during the forecast period. The growth in this region is primarily driven by the high number of manufacturers in the region and the increased consumer pool due to the increase in population, along with the increasing geriatric population in countries like China and Japan, increasing prevalence of chronic diseases in developing countries, and increasing adoption of home healthcare as an alternative to hospitals in the region.

Download Free Sample Report Now: https://www.meticulousresearch.com/download-sample-report/cp_id=5524?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=01-12-2023

Monday, April 13, 2020

REAL-WORLD EVIDENCE (RWE) SOLUTIONS MARKET WORTH $1.64 BILLION BY 2024


Real World Evidence (RWE) Solutions Market by Component (RWD, EMR, Claim, Patient Registry, Pharmacy, Service), Application (Oncology, CVD, Neuro, Infection, Regulatory), End User (Pharma, Biotech, Medical Devices, Payers, Healthcare) - Global Forecast to 2024.

A report into the projected growth of the current Real-World Evidence (RWE) solutions market by Meticulous Research® has produced lucrative forecasts for the industry. By 2024, it’s expected to have grown at a compound annual growth rate (CAGR) of 15.0%, reaching $1.64 billion.

Future Outlook: Real-World Evidence (RWE) Solutions Market to Witness Lucrative Growth during the Forecast Period (2019-2024)

In a report published today, Meticulous Research® has stated that the size of the global Real-World Evidence (RWE) solutions market will reach an impressive $1.64 billion by 2024.

The researchers suggest that the growth of Real-World Evidence (RWE) solutions market will be driven by factors including the rising geriatric population and burden of chronic diseases, shift towards value-based care, increasing R&D expenditure by the life sciences industry, delays in drug development and the subsequent increase in development costs, and expanding use of RWE for regulatory decision making.

The report states that data sets currently account for the largest share of the total market and is expected to grow at a CAGR of 13.8% from 2019 to 2024. Meticulous Research® identified as to why this segment will continue dominating over real-world evidence services: “Due to increasing need for additional insights on epidemiology, compliance, adherence and costs in a realistic environment; growing amount of medical data generated in hospitals; increasing dependence of outcome-based studies on real-world data; and rising demand for information by the payers, regulatory bodies and providers regarding drug safety.”

Get Free Sample Copy of This Report at:

Based on application, drug development and approvals commanded the largest share in 2018 owing to significant demand of RWD and RWE to accelerate drug discovery and development, increasing investment by biopharmaceutical companies in R&D, and growing inclination of regulatory bodies towards RWE. However, adoption of RWE for market access and reimbursement/coverage decisions is expected to witness fastest growth.

Pharmaceutical, biotechnology & medical device companies were the leading adopters of real-world evidence solutions in 2018 and are also expected to register fastest growth during the forecast period. This is attributed to the increasing importance of RWE studies in drug development and approvals, growing focus to avoid costly drug recalls, increasing need to assess drug performance in real-world settings, and growing emphasis on drug safety and post-market surveillance.

The report further speculates that North America is currently home for most of the real-world evidence solutions providers and is the leading adopter of RWD and RWE. The largest as well as fastest growth of this region is supported by significant availability of real-world data sets, growing focus on value-based care, rising R&D expenditure by the biopharma companies, greater emphasis on early drug/device development and approvals, stringent regulations for drug approvals, and favorable government policies (implementation of 21st Century Cures Act (December 2016) and FDA’s new 2019 strategic Framework for RWE (December 2018) in the U.S).

The key players operating in the global real-world evidence (REW) solutions market are Anthem, Inc., Clinigen Group plc, Cognizant, IBM Corporation, ICON plc, IQVIA, Optum,Inc., Oracle Corporation, PAREXEL International Corporation, PerkinElmer Inc., Pharmaceutical Product Development, LLC., SAS Institute Inc., and Syneos Health among others.



Key questions answered in the report:
Shift towards value-based care & Growing focus on personalized health care to drive the adoption of RWE Solutions 
  • How the penetration of RWE Solutions in Drug Development & Approvals does is differ from that in Market Access & Reimbursement/Coverage Decisions applications?
  • What impact does this have on the adoption of RWE Solutions to other conventional technologies for various applications?
Pharmaceutical, biotechnology and medical device companies account for largest proportion of all End-user of RWE solution globally 
  • What factors contribute to the frequent usage of RWE solution for Pharmaceutical, biotechnology and medical device?
  • Conversely, which geographic segment is expected to experience the fastest growth for Pharmaceutical, biotechnology and medical device?
The North American RWE solution market favours both larger and local manufacturers that compete in multiple segments 
  • Who are the top competitors in this market and what strategies do they employ to gain shares?
  • What is driving growth and which market segments have the most potential for revenue expansion during the forecast period?
Recent new service launches, acquisitions, collaborations, partnerships, and expansions have taken place in the RWE solution space. 
  • What companies have recently merged/acquired and how will these unions affect the competitive landscape of the RWE solution space?
  • What companies have created partnerships and how will these partnerships promote a competitive advantage?
Download Sample of Report, published in Feb 2019, key industry insights spread across 166 pages with 134 market data tables & 49 figures & charts from the report: @ https://www.meticulousresearch.com/download-sample-report/cp_id=4954

Scope of the Report:
RWE Solutions Market, by Component
  • Data Sets
    • Disparate data sets
      • EMR/EHR/Clinical data
      • Pharmacy data
      • Product/disease registries
      • Claims & billing Data
      • Other data
    • Integrated data sets
  • Consulting/ Services
 RWE Solutions Market, by Application
  • Drug development & approvals, by Therapeutic Area
    • Oncology
    • Cardiovascular Disease
    • Neurology
    • Immunology
    • Other Therapeutic Areas
  • Market access & reimbursement/coverage decisions
  • Medical device development & approvals
  • Clinical decision-making
  • Other applications
 RWE Solutions Market, by End User
  • Pharmaceutical, biotechnology & medical device companies
  • Healthcare payers
  • Healthcare providers
  • Other End users
 RWE Solutions Market, by Geography
Browse More Report of This Category at:
Healthcare IT Market by Product (EMR, mHealth, PHM, RIS, PACS, RCM, Healthcare Analytics, Telehealth, SCM, HIE), Component (Software, Service), Delivery Mode (Web, Cloud) and End User (Hospital, Payer, Pharmacy, Ambulatory, Homecare)- Global Forecast to 2027
Medical/Hospital Beds Market by Product (Bed, Accessories), Technology (Power, Manual), Type of Care (Curative, Rehabilitation), Healthcare Facilities (Critical, Bariatric, Long-term, Paediatric, Maternal, Home Care) – Global Forecast to 2027
Healthcare Virtual Assistants Market by Product (Chatbot and Smart Speaker), Technology (Speech Recognition, Text-to-Speech, and Text Based), End User (Providers, Payers, and Other End User), and Geography–Global Forecast to 2025
Healthcare Chatbots Market by Component, Deployment (On-premise and Cloud-based), Application (Symptom Checking, Medication Assistance and Guidance, Coverage and Claims Management, Appointment Management), End User, and Geography - Global Forecast to 2025

Monday, January 6, 2020

𝐍𝐨𝐧 𝐈𝐧𝐯𝐚𝐬𝐢𝐯𝐞 𝐏𝐫𝐞𝐧𝐚𝐭𝐚𝐥 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 (𝐍𝐈𝐏𝐓) 𝐌𝐚𝐫𝐤𝐞𝐭 𝟐𝟎𝟏𝟗-𝟐𝟎𝟐𝟕: 𝐌𝐚𝐫𝐤𝐞𝐭 𝐛𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭, 𝐌𝐞𝐭𝐡𝐨𝐝, 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧, 𝐚𝐧𝐝 𝐭𝐨𝐩 𝐤𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬

Meticulous Research®– leading global market research company published a research report titled “Non Invasive Prenatal Testing (NIPT) Market by Product (Consumables, NGS, Ultrasound, Microarray, PCR), Method (Ultrasound Screening, Cell Free DNA Test), Application (Trisomy, Sex Chromosome Abnormalities), & End User – Forecast to 2027”. 
According to this latest publication from Meticulous Research®, the Global Non-Invasive Prenatal Testing Market is expected to grow at a CAGR of 17.1% from 2019 to exceed $13.6 billion by 2027. The high growth of non-invasive prenatal testing market is mainly attributed to the high risk of chromosomal abnormalities with increasing maternal age, rise in occurrences of chromosomal aneuploidies among fetus, development of advanced and new technologies and non-invasive parenteral testing products, and improving reimbursement scenario for NIPT. Rising awareness regarding non-invasive prenatal testing and untapped market opportunity in emerging markets offer significant growth opportunities for the players operating in this market. However, strict regulatory guidelines and ethical hurdles are some of the key factors challenging the adoption of non-invasive prenatal testing products over the coming years.
Table of content
1.Introduction  
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency and Limitations
1.3.1. Currency
1.3.2. Limitations
1.4. Key Stakeholders
2.Research Methodology    
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation
3. Executive Summary    
4. Market Insights
4.1. Introduction
4.2. Drivers     
4.2.1. Increase in Progressive Maternal Age
4.2.2. Rise in Occurrences of Chromosomal Aneuploidies Among Foetus
4.2.3. Availability of Reimbursement Scenario for NIPT
4.2.4. Development of Advanced and New Technologies and Non-Invasive Parenteral Testing Products
4.3. Restraint
4.3.1. High Cost of the Non-invasive Prenatal Screening Techniques
4.4. Opportunities     
4.4.1. Rising Awareness Regarding NIPT
4.4.2. Untapped Emergence of New Market
4.5. Challenges
4.5.1. Reliability of the Tests
5. Global NIPT Market, by Product and Solution
5.1. Introduction
5.2. Consumables
5.3. Systems
5.3.1. Nuchal Translucency Ultrasound Devices
5.3.2. Next-Generation Sequencing Systems
5.3.3. Microarrays
5.3.4. Polymerase Chain Reaction Instruments
5.4. Software
5.5. Services
6. Global NIPT Market, by Method
6.1. Introduction
6.2. Ultrasound Screening
6.3. Cell-Free DNA Screening    …………Continue
Growth prospects in NIPT market
The global non-invasive prenatal testing market study presents historical market data in terms of values (2017 and 2018), estimated current data (2019), and forecasts for 2027-by product and solutions (consumables, instruments, software, services), method (ultrasound detection, biochemical screening tests, cellfree DNA in maternal plasma tests), application (trisomy, microdeletion syndrome, others), and end users. The study also evaluates industry competitors and analyzes the market at a regional and country level.
On the basis of products and solutions, the NIPT services segment is expected to grow at the fastest CAGR during the forecast period. The highest CAGR of this segment is mainly attributed to factors such as rising incidence of genetic disorders, increasing focus on prenatal screening, and government initiatives to provide prenatal testing services.
On the basis of application, trisomy segment is estimated to account for the largest share of the overall NIPT market in 2019. The large share of this segment is mainly attributed to the factors such as increasing maternal age and rising incidence of chromosomal abnormalities.
On the basis of end user, diagnostic laboratories segment is estimated to account for the largest share of the overall NIPT market in 2019, due to large volume of NIPT testing done at diagnostic laboratories owing to availability of the well-equipped facility and trained/skilled laboratory technicians. The initiatives taken by diagnostic laboratories to provide high quality testing services is driving the growth in this market.
Download sample copy of report before purchasing this report @  https://www.meticulousresearch.com/request-sample-report/cp_id=5068
This research report analyzes major geographies and provides comprehensive analysis for North America (U.S., Canada), Europe (Germany, France, the U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, and RoAPAC), Latin America, and Middle East & Africa. North America commanded the largest share of the global non-invasive prenatal testing market, followed by Europe and Asia-Pacific. High diagnostic and treatment rate of trisomy disorders and the emergence of key organizations in the U.S. are accelerating the non-invasive prenatal testing market in the North American region. However, Asia Pacific region is expected to grow at the highest CAGR during the forecast period due to developing healthcare infrastructure, rising focus of prominent players on expanding their presence in Asia, and rising awareness programs & conferences.
The key players operating in the global non-invasive prenatal testing market are Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), PerkinElmer, Inc. (U.S.), Illumina, Inc. (U.S.), Beijing Genomics Institute (China), Eurofins LifeCodexx AG (Germany), NATERA, INC. (U.S.), Igenomix SL (Spain), Laboratory Corporation of America Holdings (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), GE Healthcare (U.S.), and Yourgene Health (U.K.) among others.
Key questions answered in the report-
  • Which are the high growth market segments in terms of product & solutions, method, application, end-users, and region/countries?
  • What was the historical market for non-invasive prenatal testing across the globe?
  • What are the market forecasts and estimates for the period 2019-2027?
  • What are the major drivers, restraints, opportunities, and trends in the global non-invasive prenatal testing market?
  • Who are the major players in the non-invasive prenatal testing market?
  • How is the competitive landscape and who are the market leaders in the global non-invasive prenatal testing market?
  • What are the different strategies adopted by the major players in the global non-invasive prenatal testing market?
  • What are the geographical trends and high growth regions/ countries?
Contact Us:
Meticulous Research®
Contact Sales- +1-646-781-8004